Skip to main content

CleopatraRX

CleopatraRX Featured on ABC7 in Spotlight on Menopause Brain Fog and Women’s Brain Health

Los Angeles, CA – May 20, 2025

CleopatraRX, a women’s health company focused on cognitive symptoms during perimenopause and menopause, was featured on ABC7 in a segment highlighting the growing need for solutions that support women’s brain health. The piece included commentary from Dr. Rhonda Voskuhl, a leading neuroscientist and founder of CleopatraRX, whose research explores how hormonal changes influence cognition and brain aging.

During the ABC7 segment, Dr. Voskuhl explained the biological reasons many women experience brain fog during menopause. She shared evidence from decades of research showing how changes in estrogen levels affect memory, concentration, and overall cognitive performance. Her discussion brought national attention to the importance of recognizing menopause related cognitive symptoms and the need for treatment approaches that address brain health.

CleopatraRX created PearlPAK to address this unmet need. PearlPAK combines estriol and progesterone in a daily hormone therapy protocol designed to support cognitive function and reduce menopause related symptoms. The company has continued to expand its clinical partnerships and patient education efforts to make brain health a central part of menopause care.